H2020 EU funding
SINERGIA: Advanced technologies for drug discovery and precision medicine: in vitro modelling human physiology and disease
Funding scheme: MSCA-ITN-ETN-2019
SINERGIA is a project funded by the European Union in the framework of the H2020 Marie Skłodowska Curie Actions – Innovative Training Networks. SINERGIA aims to provide breakthrough strategies for the implementation of new in vitro preclinical platforms in terms of innovative technologies, biological models and drug screening approaches in the effort of bridging the gap between current, simplistic in vitro cultures and faithful and effective future physiological models.
SINERGIA beneficiaries consist of five universities (POLIMI, UNIBAS, UMaastricht, ICRC Brno, UKA) and five non-academic partners: 1 large enterprise (ACCELERA), 3 SMEs (LIFETEC, BIOMIMX and MTTLAB) and 1 hospital (EOC). Four partner organizations are also involved: 3 hospitals (MONZINO, EIO, IOG) and 1 SME (ST-UK).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860715.
uHeart: A beating Heart-on-Chip for pre-clinical early detection of drugs cardiac safety
Funding scheme: SME Instrument phase 1
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 888726.